Summary
To determine whether autoantibodies to the insulin receptor may represent markers of Type 1 (insulin-dependent) diabetes, the prevalence of such antibodies was investigated in sera of 60 newly diagnosed untreated Type 1 diabetic patients. A sensitive assay, based on enzyme linked immunosorbent assay has been set up which detects antibodies to the insulin receptor irrespective of their potentially inhibiting effect on insulin binding. Moreover, this method allows easy determination of the immunoglobulin class involved in the anti-receptor activity. Among the 60 sera examined, only one was found to contain anti-insulin receptor autoantibodies (IgG class). In view of our data, we conclude that autoantibodies to the insulin receptor are infrequent findings in Type 1 diabetes of recent onset.
Article PDF
Similar content being viewed by others
References
Bottazzo GF, Pujol-Borrell R, Gale E (1986) Autoimmunity and diabetes: progress, consolidation and controversy. In: Alberti KGMM, Krall LP (eds) The diabetes annual 2. Elsevier, London pp 13–29
Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP (1986) Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes 35: 139–142
Eisenbarth GS (1986) Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314: 1360–1368
Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–143
Vardi P, Dibella EE, Pasquarello TJ, Srikanta S (1987) Islet cell autoantibodies: pathobiology and clinical applications. Diabetes Care 10: 645–656
Atkinson MA, MacLaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP (1986) Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 35: 894–898
Maron R, Elias D, de Jongh BM, Bruining GJ, Van Rood JJ, Shechter Y, Cohen IR (1983) Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes. Nature 303: 817–818
Ludwig SM, Faiman C, Dean HJ (1987) Insulin and insulin-receptor autoantibodies in children with newly diagnosed IDDM before insulin therapy. Diabetes 36: 420–425
Boden G, Fujita-Yamaguchi Y, Shimoyama R, Shelmet JJ, Tappy L, Rezvani I, Owen OE (1988) Nonbinding inhibitory antiinsulin receptor antibodies. J Clin Invest 81: 1971–1978
Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J (1976) The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med 294: 739–745
Flier JS, Kahn CR, Jarrett DB, Roth J (1976) Characterization of antibodies to the insulin receptor. A cause of insulin-resistant diabetes in man. J Clin Invest 58: 1442–1449
Taylor SI, Grunberger G, Marcus-Samuels B, Underhill LH, Dons RF, Ryan J, Roddam RF, Rupe CE, Gorden P (1982) Hypoglycaemia associated with antibodies to the insulin receptor. N Engl J Med 307: 1422–1426
Elias D, Cohen IR, Shechter Y, Spirer Z, Golander A (1987) Antibodies to insulin receptor followed by anti-idiotype. Antibodies to insulin in child with hypoglycemia. Diabetes 36: 348–354
De Pirro R., Borboni P, Lauro R, Festa A, Testa I, De Martinis C, Maddux BA, Goldfine ID (1985) Tissue-specific antibodies against the fibroblast insulin receptor in a patient with lupus nephritis and hypoglycemia. Diabetes 34: 1088–1091
Braund WJ, Williamson DH, Clark A, Naylor BA, Buley ID, Chapel HM, Turner RC (1987) Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease. Lancet I: 237–240
Walters EG, Denton RM, Tavaré JM, Walters G (1987) Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease. Lancet I: 241–243
Moller DE, Ratner RE, Borenstein DG, Taylor SI (1988) Auto-antibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus. Am J Med 84: 334–338
Rochet N, Blanche S, Carel JC, Fischer A, Deist FL, Griscelli C, Van Obberghen E, Le Marchand-Brustel Y (1989) Hypogly-caemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child. Diabetologia 32: 167–172
Flier JS, Kahn CR, Jarrett DB, Roth J (1977) Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes. J Clin Invest 60: 784–794
Le Marchand-Brustel Y, Gorden P, Flier JS, Kahn CR, Freychet P (1978) Anti-insulin receptor antibodies inhibit insulin binding and stimulate glucose metabolism in skeletal muscle. Diabetologia 14: 311–317
Taylor SI, Samuels B, Roth J, Kasuga M, Hedo JA, Gorden P, Brasel DE, Pokora T, Engel RR (1982) Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance. J Clin Endocrinol Metab 54: 919–930
Taylor SI, Underhill LH, Marcus-Samuels B (1982) Assay of antibodies directed against cell surface receptors. Methods Enzymol 109: 656–667
Bloise W, Wajchenberg BL, Moncada VY, Marcus-Samuels B, Taylor SI (1989) Atypical anti insulin receptor antibodies in a patient with type B insulin resistance and scleroderma. J Clin Endocrinol Metab 68: 227–231
McClain DA, Maegawa H, Lee J, Dull TJ, Ullrich A, Olefsky JM (1987) A mutant insulin receptor with defective tyrosine kinase displays no biological activity and does not undergo endocytosis. J Biol Chem 262: 14663–14671
Van Obberghen E, Kasuga M, Le Cam A, Hedo JA, Itin A, Harrison LC (1981) Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes. Proc Natl Acad Sci USA 78: 1052–1056
Tanti JF, Grémeaux T, Rochet N, Van Obberghen E, Le Marchand-Brustel Y (1987) Effect of cyclic AMP-dependent protein kinase on insulin receptor tyrosine kinase activity. Biochem J 245: 19–26
Bottazzo GF, Gleichmann H (1986) Immunology and Diabetes Workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 29: 125–126
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Baron V, Gautier N, Rochet N, Ballotti R, Rossi B, Saint-Pierre S, Van Obberghen E, Dolais-Kitabgi J (1989) Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation. Biochem J 260: 749–756
Vardi P, Ziegler AG, Mathews IH, Dib S, Keller RJ, Ricker AT, Wolfsdorf JI, Herskowitz RD, Rabizadeh A, Eisenbarth GS, Soeldner JS (1988) Concentration of insulin autoantibodies at onset of Type 1 Diabetes. Inverse Log-linear correlation with age. Diabetes Care 11: 737–739
Salvi M, Fukazawa H, Bernard N, Hiromatsu Y, How J, Wall JR (1988) Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders. Endocrine Rev 4: 450–466
Shechter Y, Maron R, Elias D, Cohen IR (1982) Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science 216: 542–545
Shechter Y, Elias D, Maron R, Cohen IR (1984) Mouse antibodies to the insulin receptor developing spontaneously as antiidiotypes. I. Characterization of the antibodies. J Biol Chem 259: 6411–6415
Elias D, Maron R, Cohen IR, Shechter Y (1984) Mouse antibodies to the insulin receptor developing spontaneously as antiidiotypes. II. Effects on glucose homeostasis and the insulin receptor. J Biol Chem 259: 6416–6419
Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EAM, Bottazzo GF (1986) Insulin autoantibodies in the prediabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 29: 339–342
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rochet, N., Sadoul, J.L., Ferrua, B. et al. Autoantibodies to the insulin receptor are infrequent findings in Type 1 (insulin-dependent) diabetes mellitus of recent onset. Diabetologia 33, 411–416 (1990). https://doi.org/10.1007/BF00404090
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404090